OrbiMed’s Neuropace NPCE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$29.1M	Sell	2,614,184 -792,151	-23%	-$8.82M	0.73%	35
2025 Q1	$41.9M	Hold	3,406,335	–	–	1%	30
2024 Q4	$38.1M	Hold	3,406,335	–	–	0.78%	37
2024 Q3	$23.7M	Hold	3,406,335	–	–	0.43%	58
2024 Q2	$25.8M	Sell	3,406,335 -597,632	-15%	-$4.52M	0.51%	50
2024 Q1	$52.9M	Hold	4,003,967	–	–	0.97%	35
2023 Q4	$41.3M	Sell	4,003,967 -8,314	-0.2%	-$85.7K	0.82%	42
2023 Q3	$39M	Hold	4,012,281	–	–	0.83%	45
2023 Q2	$18M	Hold	4,012,281	–	–	0.33%	73
2023 Q1	$18.6M	Hold	4,012,281	–	–	0.37%	69
2022 Q4	$5.98M	Hold	4,012,281	–	–	0.11%	89
2022 Q3	$15K	Hold	4,012,281	–	–	0.28%	75
2022 Q2	$19.9K	Hold	4,012,281	–	–	0.36%	62
2022 Q1	$32.9M	Hold	4,012,281	–	–	0.53%	51
2021 Q4	$40.4M	Hold	4,012,281	–	–	0.52%	55
2021 Q3	$63.6M	Hold	4,012,281	–	–	0.7%	45
2021 Q2	$95.5M	Buy	+4,012,281	New	+$95.5M	0.97%	32